Lombard Odier Asset Management (Switzerland)’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$2.62M Sell
2022
Q2
$2.32M Sell
2022
Q1
$5.72M Sell
2021
Q4
$10.7M Buy
2021
Q3
$8.83M Buy
2021
Q2
$14.2M Buy
2021
Q1
$8.73M Buy